Brief: Instil Bio Announces IND Clearance Of First CoStAR-TIL Program, Itil-306, Designed To Enhance Activity In Tumor Microenvironment
27/05/2022 12:25
May 27 (Reuters) - Instil Bio Inc TIL.O :
* INSTIL BIO ANNOUNCES IND CLEARANCE OF FIRST COSTAR-TIL
PROGRAM,
ITIL-306, DESIGNED TO ENHANCE ACTIVITY IN THE TUMOR
MICROENVIRONMENT
* INSTIL BIO- TO PRESENT IN VIVO DATA WITH COSTAR T CELLS
DEMONSTRATING ENHANCED EXPANSION, PERSISTENCE, AND TUMOR CONTROL
AT 2022 ASCO ANNUAL MEETING
Source text for Eikon: ID:nGNX3jMmDx
Further company coverage: TIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Instil Bio
See all newsInstil Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Instil Bio Q2 net loss narrows on lower R&D spending, restructuring charges
Brief: Instil Bio Q2 Basic EPS USD -0.63
Instil Bio, Inc. expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio Q1 net loss narrows on lower R&D expenses